产丁酸肠道菌群定植对异基因造血干细胞移植后呼吸道病毒感染的影响
研究对360例异基因造血干细胞移植患者移植时粪便行16S rRNA测序及短链脂肪酸检测,随访180天。149例(41.4%)发生呼吸道病毒感染,其中47例(31.5%)进展为下呼吸道感染。产丁酸菌丰度较高者发生病毒性下呼吸道感染的风险降低五倍(校正HR=0.22,95%CI 0.04-0.69)。
要点
- 360例allo-HCT患者中149例(41.4%)发生呼吸道病毒感染。
- 其中47例(31.5%)进展为下呼吸道感染(LRTI)。
- 产丁酸菌丰度较高者病毒性LRTI风险降低五倍(校正HR=0.22,95%CI 0.04-0.69)。
核心结论
- 粪便微生物中产丁酸菌丰度较高与allo-HCT患者对呼吸道病毒感染进展为LRTI的抵抗力增加相关。
研究设计与样本
- 在干细胞植入时采集360例allo-HCT患者的粪便样本,行深度16S核糖体RNA基因测序以确定微生物群组成,并在嵌套子集粪便样本中测定短链脂肪酸水平。
- 移植后随访180天,确定呼吸道病毒感染和LRTI的发生情况,随后采用生存分析评估LRTI的临床和微生物群危险因素。
主要发现
- 呼吸道病毒感染发生于149例(41.4%)患者,其中47例(31.5%)进展为LRTI。
- 产丁酸菌丰度较高的患者发生病毒性LRTI的可能性降低五倍,且独立于其他因素(校正风险比=0.22,95%置信区间0.04-0.69)。
关键数值与推荐
- 产丁酸菌丰度较高者病毒性LRTI的校正风险比=0.22(95%置信区间0.04-0.69)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Respiratory viral infections are frequent in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT) and can potentially progress to lower respiratory tract infection (LRTI). The intestinal microbiota contributes to resistance against viral and bacterial pathogens in the lung. However, whether intestinal microbiota composition and associated changes in microbe-derived metabolites contribute to the risk of LRTI following upper respiratory tract viral infection remains unexplored in the setting of allo-HCT. Fecal samples from 360 allo-HCT patients were collected at the time of stem cell engraftment and subjected to deep, 16S ribosomal RNA gene sequencing to determine microbiota composition, and short-chain fatty acid levels were determined in a nested subset of fecal samples. The development of respiratory viral infections and LRTI was determined for 180 days following allo-HCT. Clinical and microbiota risk factors for LRTI were subsequently evaluated using survival analysis. Respiratory viral infection occurred in 149 (41.4%) patients. Of those, 47 (31.5%) developed LRTI. Patients with higher abundances of butyrate-producing bacteria were fivefold less likely to develop viral LRTI, independent of other factors (adjusted hazard ratio = 0.22, 95% confidence interval 0.04-0.69). Higher representation of butyrate-producing bacteria in the fecal microbiota is associated with increased resistance against respiratory viral infection with LRTI in allo-HCT patients.
引用
- Haak BW, Littmann ER, Chaubard JL, et al. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018. PMID: 29674425. doi:10.1182/blood-2018-01-828996
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。